References
- World Health Organization. Introduction of hepatitis B vaccine into childhood immunization services. Geneva: WHO; 2001.
- World Health Organization. Hepatitis B fact sheet number 204. Geneva: WHO; 2008.
- Tsi W-L, Tsung RT. Viral hepatocarcinogenesis. Oncogene 2010; 29:2309–2324.
- Nath A, Agarwal R, Malhotra P, . Prevalence of hepatitis B virus infection in non-Hodgkin's lymphoma. A systematic review and meta-analysis. Intern Med J 2009;40:633–41.
- Lerat H, Rumin S, Habersetzer F, . In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 1998;91:3841–3849.
- Marcucci F, Mele A. Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis and therapeutic opportunities. Blood 2010;117:1792–1798.
- Huang B, Li J, Zhou Z, . High prevalence of hepatitis B infection in multiple myeloma. Leuk Lymphoma 2011;52:270–274.
- Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 2007;136:699–712.
- Yeo W, Chan PK, Zhong S, . Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors .J Med Virol 2000;62:299–307.
- Huang SY, Yao M, Tang JL, . Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years. Cancer 2007;110:896–905.
- Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002;2:395–403.